CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Attovia extends biotech IPO streak with $289M listing for three I&I drugs

IPO/OfferingPositive
AI Analysis

Summary

Attovia Therapeutics completed a $289M IPO, extending the biotech industry's consecutive weekly offering streak. The immunology and inflammation-focused company is developing three drugs in the I&I space.

Importance:6/10
Sentiment:
0.60
IPOimmunologyinflammationcapital_raising
Related Companies

Read the original article

Published by Endpoints News on August 5, 2026 11:00 AM

Read Original